Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Journal
Dermatology online journal
ISSN: 1087-2108
Titre abrégé: Dermatol Online J
Pays: United States
ID NLM: 9610776
Informations de publication
Date de publication:
15 Sep 2020
15 Sep 2020
Historique:
received:
07
10
2020
accepted:
07
10
2020
entrez:
15
10
2020
pubmed:
16
10
2020
medline:
7
9
2021
Statut:
epublish
Résumé
Lepromatous leprosy is associated with a high bacillary load and poor cellular immune response. Early dermatologic manifestations include erythematous macules, papules, nodules, and plaques with a symmetrical distribution. Leprosy also shows two major reaction states including type I (reversal reaction) and type II (vasculitis). These reactions are usually seen in some patients who are undergoing treatment. Herein, we report an interesting patient with lepromatous leprosy who presented with skin lesions of type II reaction without receiving any anti-leprosy treatment and surprisingly showed a type I reaction eight months after the beginning of the treatment.
Substances chimiques
Leprostatic Agents
0
Dapsone
8W5C518302
Clofazimine
D959AE5USF
Rifampin
VJT6J7R4TR
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM